Close  

Palace strongly denounces ambush of FDA chief’s convoy in CamSur

/ 01:15 PM October 21, 2018

Malacañang “strongly denounced” on Sunday the attack on the convoy of Food and Drug Administration (FDA) Director General Nela Charade Puno in Lupi town, Camarines Sur province last Thursday.

READ: FDA chief’s convoy ambushed; 3 cops killed

ADVERTISEMENT

“We strongly denounce the ambush of Food and Drug Administration (FDA) Director-General Nela Charade G. Puno and her convoy in Camarines Sur which left at least three policemen dead and three others wounded,” Palace Spokesperson Salvador Panelo said in a statement.

The Palace, meanwhile, commended and expressed “deep condolences” to the bereaved families and loved ones of the policemen who died in their line of duty.

FEATURED STORIES

“While DG Puno is unharmed by this surprise attack, she has been advised by authorities to defer attending the wake of the policemen,” Panelo said.

“We likewise send our prayers and thoughts for the speedy recovery of the policemen who were wounded during this brazen assault,” he added.

The Palace official also ensured that investigation is now underway and that the perpetrators behind the attack will be brought to justice. /je

Read Next
LATEST STORIES
MOST READ
Don't miss out on the latest news and information.
View comments

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: ambush, Camarines Sur, CamSur, Convoy, FDA, news, Palace, PNP‎
For feedback, complaints, or inquiries, contact us.
opinion

Panic in the air

November 19, 2019 05:15 AM

opinion

Bottled air

November 19, 2019 05:13 AM

opinion

‘I will destroy her in public’

November 19, 2019 05:11 AM

newsinfo

Police find man in viral ‘Grand Taft Auto’ video 

November 19, 2019 05:10 AM

opinion

5 myths of Dutertismo (1) 

November 19, 2019 05:09 AM



© Copyright 1997-2019 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.